ArticleCureus2026
Efficacy of Low-Dose Radiotherapy for Pain Control in Elderly Patients With Advanced Knee Osteoarthritis: A Prospective Single-Arm Study From India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Osteoarthritis is one of the commonly occurring causes of disability and pain in the elderly Indian population. Low-dose radiotherapy (LDRT) has been used in Europe and the US for symptomatic management. Objectives To evaluate the efficacy of LDRT in achieving clinically significant pain reduction (≥30% improvement in Visual Analogue Scale (VAS)), its durability over 12 months, and its safety in elderly patients with advanced knee osteoarthritis who were unsuitable for or declined surgical intervention. Methods and materials One hundred and six patients aged >50 years with Kellgren-Lawrence grade III-IV knee osteoarthritis (OA) received LDRT using cobalt-60, delivering 3 Gy in six fractions (0.5 Gy/fraction, two times a week). Pain was assessed using VAS at baseline and at four weeks, four months, eight months, and 12 months. Inflammatory biomarkers (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) and treatment-related toxicity were also evaluated. Results LDRT produced a significant reduction in pain compared with baseline, with mean VAS decreasing from 7.9±0.6 to 3.5±1.2 at 4 weeks and remaining significantly improved through 12 months (4.0±0.9; all P<0.001). Overall, 88 subjects out of 90 (97.8% of evaluable subjects) achieved at least a 30% reduction in pain. CRP and ESR levels both decreased significantly after treatment (P=0.002 and 0.006, respectively). No grade ≥3 adverse events, radiation-induced tissue injury, or unexpected toxicities were observed. Conclusions LDRT was safe, well tolerated, and provided reasonable pain relief for up to 12 months in elderly patients with advanced knee OA, subject to limitations of this study. These findings support further randomized sham-controlled trials incorporating functional outcomes, quality-of-life measures, and translational biomarkers to define the role of LDRT in contemporary osteoarthritis management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.